3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma, Ewing
2
Sarcoma
2
Osteosarcoma
2
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Malignant mesenchymal tumor
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Hodgkin Disease
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Fibrosarcoma
1
Disorders of Sex Development
1
Dermatofibrosarcoma
1
Chondrosarcoma, Extraskeletal Myxoid
1
Interventions
Cytarabine
5
Whole-Body Irradiation
4
fludarabine
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Injections
3
Cyclophosphamide
3
CPX-351
3
Blood Specimen Collection
3
venetoclax
2
nilotinib
2
luspatercept
2
ivosidenib
2
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
asciminib
2
Tacrolimus
2
Mycophenolic Acid
2
Melphalan
2
Liposomes
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Gemtuzumab
2
Filgrastim
2
Daunorubicin
2
Cyclosporine
2
Busulfan
2
Biopsy
2
Azacitidine
2
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Ifosfamide
×
30 days
×
Clear all
No trials found.